A6: Difference between revisions
Jump to navigation
Jump to search
(CSV import) |
(CSV import) |
||
| Line 1: | Line 1: | ||
{{ | {{Definitions | ||
|Term=A6 | |Term=A6 | ||
}} | }} | ||
{{ | {{ Definitions | ||
|Short_definition= A substance being studied for the treatment of cancer. | |Short_definition= A substance being studied for the treatment of cancer. | ||
|Type= | |Type=Cancer terms | ||
|Specialty=Oncology | |Specialty=Oncology | ||
|Language=English | |Language=English | ||
Revision as of 00:47, 8 January 2023
| A6 | |
|---|---|
| Term | A6 |
| Short definition | |
| Type | |
| Specialty | |
| Language | |
| Source | |
| Comments | |
| A6 | |
|---|---|
| Term | |
| Short definition | |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
A6 - A substance being studied for the treatment of cancer. A6 is a small piece of a protein called urokinase (an enzyme that dissolves blood clots or prevents them from forming). It is a type of anti-angiogenesis agent and a type of anti-metastatic. Also called urokinase plasminogen activator (uPA) derived peptide A6
External links
- Medical encyclopedia article on A6
- Wikipedia's article - A6
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski